SHANGHAI - waste Foul issued by one of the largest manufacturers of drugs China are become the latest target in a growing campaign to crack down on the country serious pollution problems.
Harbin in the North China pharmaceutical group, said Thursday that it is rushing to upgrade its equipment and reduce releases of its critical antibiotics after intense drawing plants in the national media for a stench residents have been complaining about years.
China has been stepping up efforts to close or clean heavily polluting industries which have left many communities contaminated with heavy metals and other pollutants.
Reports by the State national television and major newspapers said the gas hydrogen sulfide levels near Harbin pharmaceutical plants were found to be more than 1,000 times the legal limit, while the levels of ammonia were 20 times the allowed limit.
Due largely chemicals the fermentation process used to manufacture penicillin, they said.
Exposure of hydrogen sulphide, that smell of eggs rotten and is also known as the swamp gas, can be fatal in high concentrations. It causes irritation of the skin and lower concentrations of respiratory problems and is highly flammable.
"There is no excuse for such emissions of waste and there is no advantage to escape responsibility," the newspaper of the Communist Party of people every day, said in a sharply worded comment that took local authorities to task for failing to curb the problems when they resurfaced in 2004.
Representatives of the Harbin city government refused to comment on the situation.
The barrage of criticism for what local media have dubbed "door pollution" followed reports earlier this week that authorities investigating a chemical plant which discharges of certain toxic substances 10 accused of alteration of water to parts of Hangzhou, a city of 9 million people to the West of Shanghai.
Harbin pharmaceutical issued a notice Thursday to the stock market of Shanghai acknowledging the complaints and confirming it was cutting production in some of its facilities while it solves problems.
The company said that he had invested 400 million Yuan (approximately $ 62 million) in clean technologies and pollution control equipment. The results of its last sampling of the affected areas, conducted this week, were not yet available, he said.
The company, which employs more than 20,000 people, said that it will to gaps in the production of penicillin and cephalosporin with purchases of other drug manufacturers.
没有评论:
发表评论